Targeting the DNA Damage Response for Anti-Cancer Therapy
Broschiertes Buch

Targeting the DNA Damage Response for Anti-Cancer Therapy

Versandkostenfrei!
Versandfertig in 6-10 Tagen
149,99 €
inkl. MwSt.
PAYBACK Punkte
75 °P sammeln!
Over the past decade a complex role for DNA damage response (DDR) in tumorigenesis has emerged. A proficient DDR has been shown to be a primary cause for cellular resistance to the very many DNA damaging drugs, and IR, that are widely used as standard-of-care across multiple cancer types. It has also been shown that defects in this network, predominantly within the ATM mediated signaling pathway, are commonly observed in cancers and may be a primary event during tumorigenesis. Such defects may promote a genomically unstable environment, facilitating the persistence of mutations, any of which m...